-
公开(公告)号:US20220073477A1
公开(公告)日:2022-03-10
申请号:US17481649
申请日:2021-09-22
IPC分类号: C07D249/06 , C07C309/30 , A61K9/00 , A61K31/496 , C07D239/26 , A61K31/506 , C07D295/192 , A61K31/495 , C07D279/12 , A61K31/54 , C07D205/04 , A61K31/397 , C07D295/26 , C07D215/54 , C07C53/18 , C07D231/12 , C07D263/32 , A61K31/541 , C07B59/00 , C07D403/12 , A61K31/4192 , C07D401/12 , A61K31/454 , C07D249/08 , A61K31/4196 , C07D211/66 , A61K31/445 , C07D239/42 , C07D491/107 , C07D413/12 , A61K31/5377 , C07D498/08 , A61K31/5383 , C07D471/10 , A61K31/435 , C07D401/04 , A61K31/41 , C07D487/04 , A61K31/4162 , C07D487/08 , A61K31/4995 , A61K31/551 , C07D237/08 , A61K31/501 , A61K9/16 , A61K9/48 , A61K45/06 , A61P29/00 , A61P35/00 , A61P35/02 , A61P43/00
摘要: Disclosed herein are new compounds and compositions and their application as pharmaceuticals for the treatment of diseases. Methods of inhibition of KDM1A, methods of increasing gamma globin gene expression, and methods to induce differentiation of cancer cells in a human or animal subject are also provided for the treatment of diseases such as acute myelogenous leukemia.
-
72.
公开(公告)号:US20220072163A1
公开(公告)日:2022-03-10
申请号:US17253430
申请日:2019-06-28
发明人: Jennifer M. Murphy , Gaoyuan Ma
IPC分类号: A61K51/04 , C07B59/00 , A61K51/08 , C07D233/70
摘要: Site-selective conjugation to biomolecules via thiol-based chemistry is superior to the unselective modification of lysine residues, which produce a mixed product and can potentially interfere with binding affinity of the biomolecule. However, in physiological environments, the maleimide-thiol conjugation product which is the current gold-standard for site-selective thiol-conjugation can be susceptible to hydrolysis or a retro-Michael reaction via exchange with reactive thiols such as those in albumin or glutathione residues yet the degradation is relatively slow. Therefore, for in vivo studies, the maleimide-thiol conjugation proposes instability issues. The compositions and methods disclosed herein provide an alternative thiol-based linkage, one that overcomes the instability issues with conventional reagents and methods. The compositions and methods disclosed herein are useful in various contexts, for example, for 18F-labeling of peptides/proteins in the preparation of positron emission tomography (PET) probes.
-
公开(公告)号:US20220062445A1
公开(公告)日:2022-03-03
申请号:US17522249
申请日:2021-11-09
发明人: David PERRIN , Zhibo LIU
摘要: Fluoridated organofluoroborates comprising at least one 18F atom and precursors thereto, for use in PET scanning.
-
公开(公告)号:US11261171B1
公开(公告)日:2022-03-01
申请号:US16680969
申请日:2019-11-12
发明人: Gianni Chessari , Steven Howard , Ildiko Maria Buck , Benjamin David Cons , Christopher Norbert Johnson , Rhian Sara Holvey , David Charles Rees , Jeffrey David St. Denis , Emiliano Tamanini , Bernard Thomas Golding , Ian Robert Hardcastle , Celine Florence Cano , Duncan Charles Miller , Martin Edward Mäntylä Noble , Roger John Griffin , James Daniel Osborne , Joanne Peach , Arwel Lewis , Kim Louise Hirst , Benjamin Paul Whittaker , David Wyn Watson , Dale Robert Mitchell
IPC分类号: C07D401/06 , A61K31/5377 , A61K31/506 , A61K31/501 , A61K31/496 , A61K31/4545 , A61K31/444 , A61K31/4439 , A61P35/00 , C07D417/14 , C07D409/14 , C07D407/14 , C07D403/06 , C07D401/14 , C07D405/14 , C07D413/14 , C07D403/14 , C07D487/04 , C07B59/00 , C07D487/08 , A61K45/06
摘要: The invention provides a compound of formula (I): or tautomer or a solvate or a pharmaceutically acceptable salt thereof, wherein the various substituents are as defined in the claims. Also provided are pharmaceutical compositions containing the compounds of formula (I), processes for making the compounds and the medical uses of the compounds.
-
公开(公告)号:US20220017433A1
公开(公告)日:2022-01-20
申请号:US17295457
申请日:2019-11-21
申请人: UNIVERSITÄT ZÜRICH
发明人: Jason Philip HOLLAND , Malay PATRA
摘要: The invention relates to a method for labeling a target compound with a radiometal by photochemically induced conjugation. Furthermore, a chelating compound for use in said method is provided. The chelating compound is characterized by an arylazide moiety which can be photo-conjugated to a target compound and a chelator moiety which can be radiolabelled. The photo-conjugation and radiolabelling are both performed at basic pH performed in a simultaneous one-pot reaction.
-
公开(公告)号:US11219875B2
公开(公告)日:2022-01-11
申请号:US15565740
申请日:2016-04-14
申请人: PMB
摘要: Disclosed is a device for the synthesis of a radiotracer, including a universal confined enclosure designed for the insertion of a specific synthesis cassette of the radiotracer and the removal of same. The synthesis cassette includes a synthesis module designed to receive reagents and a radioisotope for the synthesis of the radiotracer. An inner connector plate includes at least one inlet, designed to be connected to a radioisotope admission and also to the inlet of the cassette, and an outlet, designed to be connected to a syringe to be filled with the radiotracer and also to the outlet of the cassette. Such a synthesis device can be installed in a facility including, in a confined room, as well as such devices normally arranged in a storage area, a synthesis station, a radioisotope admission, at least one window for communication to the outside, and a manipulator robot.
-
公开(公告)号:US20210387938A1
公开(公告)日:2021-12-16
申请号:US17412797
申请日:2021-08-26
申请人: Retrotope, Inc.
IPC分类号: C07C67/30 , C07C5/00 , C07C407/00 , C07C29/00 , C07B59/00 , C07C51/347 , C07C11/12
摘要: Methods for preparing isotopically modified 1,4-diene systems from non-isotopically modified 1,4-dienes involve selective oxidation of one or more bis-allylic position(s), or the preparation of isotopically modified 1,4-diene systems via trapping pi-allylic complexes with a source of deuterium or tritium. Such methods are useful for preparing isotopically modified polyunsaturated lipid including polyunsaturated fatty acids and polyunsaturated fatty acid derivatives.
-
78.
公开(公告)号:US20210369807A1
公开(公告)日:2021-12-02
申请号:US17322493
申请日:2021-05-17
发明人: Blake Farrow , James R. Heath , Heather Dawn Agnew
IPC分类号: A61K38/00 , C07B59/00 , A61K38/12 , A61K38/06 , C07K7/52 , C07K5/083 , A61K38/08 , C07K7/06 , G01N33/531 , A61K47/60 , C07K7/08
摘要: The present application provides stable peptide-based Botulinum neurotoxin (BoNT) serotype A capture agents and methods of use as detection and diagnosis agents and in the treatment of diseases and disorders. The application further provides methods of manufacturing BoNT serotype A capture agents using iterative on-bead in situ click chemistry.
-
公开(公告)号:US11186566B2
公开(公告)日:2021-11-30
申请号:US16702891
申请日:2019-12-04
发明人: Timothy Alcacio , Minson Baek , Peter Grootenhuis , Sara Sabina Hadida Ruah , Robert M. Hughes , Ali Keshavarz-Shokri , Rachel McAuley-Aoki , Jason McCartney , Mark Thomas Miller , Fredrick Van Goor , Beili Zhang , Corey Anderson , Thomas Cleveland , Bryan A. Frieman , Haripada Khatuya , Pramod Virupax Joshi , Paul John Krenitsky , Vito Melillo , Fabrice Jean Denis Pierre , Andreas P. Termin , Johnny Uy , Jinglan Zhou , Alexander Russell Abela , Brett Bradley Busch , Prasuna Paraselli
IPC分类号: C07D401/14 , C07D471/14 , C07D498/14 , C07B59/00
摘要: Compounds of Formula I: pharmaceutically acceptable salts thereof, deuterated derivatives of any of the foregoing, and metabolites of any of the foregoing are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed.
-
公开(公告)号:US20210348208A1
公开(公告)日:2021-11-11
申请号:US17120880
申请日:2020-12-14
发明人: Roger Tung
IPC分类号: C12Q1/28 , C07B59/00 , C07D471/08 , A61K31/195 , A61K31/4709 , A61K31/485 , A61K31/49 , C07D221/28 , G01N33/49 , G01N33/493
摘要: This disclosure relates to novel morphinan compounds and their derivatives, pharmaceutically acceptable salts, solvates, and hydrates thereof. This disclosure also provides compositions comprising a compound of this disclosure and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a al receptor agonist that also has NMDA antagonist activity.
-
-
-
-
-
-
-
-
-